Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
Kestra Medical Technologies (Nasdaq: KMTS) will report its first quarter fiscal 2027 financial results after the market close on Monday, September 14.
Rhea-AI Summary
Kestra Medical Technologies (Nasdaq: KMTS) will report its first quarter fiscal 2027 financial results after the market close on Monday, September 14. Management will host a conference call at 4:30 p.m. Eastern Time, with a live and archived webcast available in the Investor Relations “Events” section.
Positive
- None.
Negative
- None.
Details
News Market Reaction – KMTS
In the Sep 1 session, KMTS declined 2.45%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Fiscal period
- First quarter fiscal 2027
- Financial results reporting period
- Reporting date
- September 14
- After the market closes
- Conference call time
- 4:30 p.m. Eastern Time
- Management discussion of financial results
Previous Earnings date Reports
-
Announcement scheduled fiscal 4Q26 results after market close on July 14
-
Announcement scheduled fiscal 3Q26 results for March 17 with conference call
-
Announcement scheduled fiscal 2Q26 results for December 11 with conference call
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 financial results after the market closes on Monday, September 14.
Management will host a conference call at 4:30 p.m. Eastern Time to discuss financial results. A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website.
About Kestra
Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com